Overall, as we learn more about this crosstalk, the ability of ZEB and SNAI family members to influence key epigenetic modulators such as LSD1 and control key cytokine signaling pathways may offer new therapeutic options for treating AML. Here, KDM1A is linked to acute myeloid leukemia.